Intercure (TSX:INCR.U) Days Sales Outstanding : 0.00 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Intercure Days Sales Outstanding?

Intercure's average Accounts Receivable for the three months ended in Dec. 2024 was $16.95 Mil. Intercure's Revenue for the three months ended in Dec. 2024 was $0.00 Mil.

The historical rank and industry rank for Intercure's Days Sales Outstanding or its related term are showing as below:

During the past 13 years, Intercure's highest Days Sales Outstanding was 85.78. The lowest was 24.82. And the median was 47.59.

TSX:INCR.U's Days Sales Outstanding is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 72.635
* Ranked among companies with meaningful Days Sales Outstanding only.

Intercure's Days Sales Outstanding declined from Mar. 2023 (40.84) to Dec. 2024 (0.00).

Intercure Days Sales Outstanding Historical Data

The historical data trend for Intercure's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intercure Days Sales Outstanding Chart

Intercure Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

39.44

24.82

25.51

49.96

85.77

Intercure Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Jun24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial															40.84	44.87	-	-	-

Competitive Comparison of Intercure's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Intercure's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intercure's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intercure's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Intercure's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Intercure Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Intercure's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (18.036	+	15.479)	/	2 )	/	71.309	*	365
=	16.7575					/	71.309	*	365
=	85.77

Intercure's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (18.413	+	15.479)	/	2 )	/	0	*	365 / 4
=	16.946					/	0	*	365 / 4
=	N/A

Intercure (TSX:INCR.U) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Intercure Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Intercure's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Intercure Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intercure Ltd (TSX:INCR.U) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

INCR:USA INCR:Israel

Address

85 Medinat ha-Yehudim Street, Herzliya, ISR, 4676670

Website

https://www.intercure.co

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Intercure Headlines

No Headlines